Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes the approval of ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), as a new first-line maintenance ...
NAD+ helps power our cells. As levels drop with age, interest is growing in how to replicate its effects – but does it work?
The intelligent use of captive arrangements could be 'a means to a solid risk management strategy, actually moving the lines ...
CStone Pharmaceuticals (“CStone,” HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Nuclear fusion usually brings to mind sprawling facilities, blistering temperatures, and machines built on a scale that can swallow budgets whole. This device does something stranger.
Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug ...
A healthy thymus in adults is tied to longer life, reduced disease risk, and improved cancer treatment response.
After many years of large capitalization companies dominating the US equities market, time is ripe for rotation.
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are ...
Scientists have developed a fuel cell that uses microbes in soil to produce electricity. The device can power underground ...
Scientists used a tool called SynTrogo to edit brain circuits in mice, showing that trimming select synapses can make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results